Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > John Canan > Profile

John Canan

Affiliations

  • Director at Rev Group Inc. (REVG), 2024-12-10
  • Director at Acasti Pharma Inc. (ACST), 2022-09-30
  • Sr.v-P Finc-Global Controller at Merck & Co. Inc. (MRK), 2014-02-26
  • Officer at Merck Sharp & Dohme Corp. (MRK), 2009-11-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
REVG $16.05 200 $3,210.00 6,363 2018-06-25 Filing
REVG $16.06 400 $6,422.00 6,163 2018-06-25 Filing
REVG $16.04 4,440 $71,213.16 5,763 2018-06-25 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MRK $55.70 10,000 $557,002.00 10,697 2014-02-11 Filing
MRK $44.29 30,500 $1,350,787.05 5,058 2012-08-01 Filing